Search Results

There are 4648 results for: content related to: Biomimetic Hydroxyapatite–Drug Nanocrystals as Potential Bone Substitutes with Antitumor Drug Delivery Properties

  1. You have free access to this content
    Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension

    Journal of Bone and Mineral Research

    Volume 19, Issue 8, August 2004, Pages: 1259–1269, Kristine E Ensrud, Elizabeth L Barrett-Connor, Ann Schwartz, Arthur C Santora, Douglas C Bauer, Shailaja Suryawanshi, Adrianne Feldstein, William L Haskell, Marc C Hochberg, James C Torner, Antonio Lombardi, Dennis M Black and for the Fracture Intervention Trial Long-Term Extension Research Group

    Version of Record online : 29 MAR 2004, DOI: 10.1359/JBMR.040326

  2. You have free access to this content
    ASBMR-IBMS second joint meeting

    Journal of Bone and Mineral Research

    Volume 13, Issue S1, November 1998, Pages: S1–S653,

    Version of Record online : 2 AUG 2011, DOI: 10.1002/jbmr.5650130102

  3. Generic alendronate use among medicare beneficiaries: are part d data complete?

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 55–63, Huifeng Yun, Jeffrey R Curtis, Kenneth Saag, Meredith Kilgore, Paul Muntner, Wilson Smith, Robert Matthews, Nicole Wright, Michael A. Morrisey and Elizabeth Delzell

    Version of Record online : 8 NOV 2012, DOI: 10.1002/pds.3361

  4. You have free access to this content
    Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: Evaluation of transdermal absorption, safety, and pharmacological effects after application in rats

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 9, September 2012, Pages: 3230–3238, Hidemasa Katsumi, Shu Liu, Yutaro Tanaka, Kaori Hitomi, Rie Hayashi, Yuka Hirai, Kosuke Kusamori, Ying-shu Quan, Fumio Kamiyama, Toshiyasu Sakane and Akira Yamamoto

    Version of Record online : 29 MAR 2012, DOI: 10.1002/jps.23136

  5. You have free access to this content
    ASBMR 29th Annual Meeting

    Journal of Bone and Mineral Research

    Volume 22, Issue S1, September 2007, Pages: s302–s351,

    Version of Record online : 4 MAR 2010, DOI: 10.1002/jbmr.5650221408

  6. You have free access to this content
    ASBMR 19th annual meeting

    Journal of Bone and Mineral Research

    Volume 12, Issue S1, August 1997, Pages: S1–S531,

    Version of Record online : 2 AUG 2011, DOI: 10.1002/jbmr.5650120103

  7. You have free access to this content
    ASBMR 22nd annual meeting

    Journal of Bone and Mineral Research

    Volume 15, Issue S1, September 2000, Pages: S1–S584,

    Version of Record online : 4 AUG 2011, DOI: 10.1002/jbmr.5650150102

  8. You have free access to this content
    ASBMR 25th Annual Meeting M001–M483

    Journal of Bone and Mineral Research

    Volume 18, Issue S1, 2003, Pages: S285–S393,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650181306

  9. You have free access to this content
    Program & Abstracts

    Journal of Bone and Mineral Research

    Volume 17, Issue S1, September 2002, Pages: S1–S502,

    Version of Record online : 4 AUG 2011, DOI: 10.1002/jbmr.5650170102

  10. You have free access to this content
    Esophageal and gastric cancer incidence and mortality in alendronate users

    Journal of Bone and Mineral Research

    Volume 27, Issue 3, March 2012, Pages: 679–686, Bo Abrahamsen, Michael Pazianas, Pia Eiken, R Graham G Russell and Richard Eastell

    Version of Record online : 21 FEB 2012, DOI: 10.1002/jbmr.1481

  11. Studies of the oral bioavailability of alendronate

    Clinical Pharmacology & Therapeutics

    Volume 58, Issue 3, September 1995, Pages: 288–298, Barry J. Gertz, Sherry D. Holland, Walter F. Kline, Bogdan K. Matuszewski, Amanda Freeman, Hui Quan, Kenneth C. Lasseter, John C. Mucklow and Arturo G. Porras

    Version of Record online : 19 SEP 1995, DOI: 10.1016/0009-9236(95)90245-7

  12. You have free access to this content
    ASBMR 26th Annual Meeting M001–M585

    Journal of Bone and Mineral Research

    Volume 19, Issue S1, 2004, Pages: S343–S484,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650191306

  13. You have free access to this content
    ASBMR 27th Annual Meeting M001–M525

    Journal of Bone and Mineral Research

    Volume 20, Issue S1, 11 August 2005, Pages: S313–S437,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650201306

  14. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation

    Journal of Cellular Physiology

    Volume 230, Issue 8, August 2015, Pages: 1944–1953, Lindsay M. Coe, Srinivasan Arjun Tekalur, Yutian Shu, Melissa J. Baumann and Laura R. McCabe

    Version of Record online : 27 APR 2015, DOI: 10.1002/jcp.24929

  15. You have free access to this content
    ASBMR 18th annual meeting

    Journal of Bone and Mineral Research

    Volume 11, Issue S1, August 1996, Pages: S1–S500,

    Version of Record online : 6 MAR 2012, DOI: 10.1002/jbmr.5650111302

  16. Incidence of adverse oesophageal and gastric events in alendronate users

    Pharmacoepidemiology and Drug Safety

    Volume 9, Issue 5, September/October 2000, Pages: 371–376, MD Byung-Joo Park, Jon Clouse, Deborah Shatin and Andy Stergachis

    Version of Record online : 27 OCT 2000, DOI: 10.1002/1099-1557(200009/10)9:5<371::AID-PDS514>3.0.CO;2-7

  17. You have free access to this content
    Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model

    Journal of Orthopaedic Research

    Volume 25, Issue 4, April 2007, Pages: 473–479, Stavros Thomopoulos, Hironori Matsuzaki, Melissa Zaegel, Richard H. Gelberman and Matthew J. Silva

    Version of Record online : 4 JAN 2007, DOI: 10.1002/jor.20293

  18. Use of bisphosphonates in the management of postmenopausal osteoporosis

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 15–32, Socrates E. Papapoulos

    Version of Record online : 29 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05767.x

  19. Osteoclast activation: Potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism

    Journal of Cellular Physiology

    Volume 172, Issue 1, July 1997, Pages: 79–86, Jane Marie Owens, Karen Fuller and Timothy John Chambers

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-4652(199707)172:1<79::AID-JCP9>3.0.CO;2-A

  20. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 5, May 2013, Pages: 1513–1523, Xiaoming Xu, Abhay Gupta, Vilayat A. Sayeed and Mansoor A. Khan

    Version of Record online : 28 FEB 2013, DOI: 10.1002/jps.23488